SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-21-240516
Filing Date
2021-08-09
Accepted
2021-08-09 16:31:44
Documents
69
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d182977d10q.htm   iXBRL 10-Q 1364717
2 EX-31.1 d182977dex311.htm EX-31.1 11016
3 EX-31.2 d182977dex312.htm EX-31.2 11158
4 EX-32.1 d182977dex321.htm EX-32.1 3280
5 EX-32.2 d182977dex322.htm EX-32.2 3422
  Complete submission text file 0001193125-21-240516.txt   5782263

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA nexi-20210630.xsd EX-101.SCH 41706
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nexi-20210630_cal.xml EX-101.CAL 38284
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nexi-20210630_def.xml EX-101.DEF 234207
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE nexi-20210630_lab.xml EX-101.LAB 407428
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nexi-20210630_pre.xml EX-101.PRE 321609
11 EXTRACTED XBRL INSTANCE DOCUMENT d182977d10q_htm.xml XML 835359
Mailing Address 9119 GAITHER ROAD GAITHERSBURG MD 20878
Business Address 9119 GAITHER ROAD GAITHERSBURG MD 20878 301-825-9810
NexImmune, Inc. (Filer) CIK: 0001538210 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40045 | Film No.: 211156969
SIC: 2834 Pharmaceutical Preparations